ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis

August 23, 1974

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999